Fingolimod improves diffuse brain injury by promoting AQP4 polarization and functional recovery of the glymphatic system.

Authors:
Feng D; Liu T; Zhang X; Xiang T; Su W and 2 more

Journal:
CNS Neurosci Ther

Publication Year: 2024

DOI:
10.1111/cns.14669

PMCID:
PMC10924110

PMID:
38459666

View on PubMed View on PMC View Publisher
Journal Information

Full Title: CNS Neurosci Ther

Abbreviation: CNS Neurosci Ther

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Therapeutics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Aberrant microstructural integrity of white matter in mild and severe orthostatic hypotension: A NO…
Cheng Y; Lin L; Jiang S and 6 more (2024) - Transparency Score: 3/6
Absence in CX3CR1 receptor signaling promotes post-ischemic stroke cognitive function recovery thro…
Ge Y; Yang J; Chen J and 5 more (2024) - Transparency Score: 3/6
Acetyl-11-keto-beta-boswellic acid modulates macrophage polarization and Schwann cell migration to …
Wang Y; Xiong Z; Qiao Y and 6 more (2024) - Transparency Score: 3/6
Activation of testosterone-androgen receptor mediates cerebrovascular protection by photobiomodulat…
Feng Y; Huang Z; Ma X and 6 more (2024) - Transparency Score: 3/6
Advancing stroke therapy: A deep dive into early phase of ischemic stroke and recanalization.
He Q; Wang Y; Fang C and 5 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST STATEMENT The authors declare no conflicts of interest."

Evidence found in paper:

"FUNDING INFORMATION The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article. This study was supported by the National Natural Science Foundation of China (no. 82071390 to R J), the Tianjin Research Program of Application Foundation and Advanced Technology (no. 19YFZCSY00650 to R J), the Clinical Study of Tianjin Medical University (no. 2017kylc007 to R J), National Natural Science Foundation of China (no. 82071402 to W Q), and National Natural Science Foundation of Tianjin (no. 20JCYBJC01380 to W Q)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025